Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anand Pai

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Plos One|October 26, 2023
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantationBalaji Balakrishnan, Raveen Stephen Stallon Illangeswaran, Bharathi Murugan Rajamani, et al.
Stem Cell Research & Therapy|December 31, 2024
Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathiesPrathibha Babu Chandraprabha, Manoj Kumar K Azhagiri, Vigneshwaran Venkatesan, et al.
Transplantation and Cellular Therapy|May 13, 2022
Endothelial Activation and Stress Index-Measured Pretransplantation Predicts Transplantation-Related Mortality in Patients with Thalassemia Major Undergoing Transplantation with Thiotepa, Treosulfan, and Fludarabine ConditioningUday P Kulkarni, Aswin Anand Pai, M L Kavitha, et al.
Scientific Reports|August 18, 2022
Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applicationsAbhirup Bagchi, Nivedhitha Devaraju, Karthik Chambayil, et al.
Cells|April 3, 2021
Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear CellsAbhirup Bagchi, Aneesha Nath, Vasanth Thamodaran, et al.
Frontiers in Genome Editing|January 6, 2023
Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2Anila George, Nithin Sam Ravi, Kirti Prasad, et al.
Frontiers in Pharmacology|June 16, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib <i>in vitro</i> and reduces disease burden <i>in vivo</i>Bharathi M Rajamani, Raveen Stephen Stallon Illangeswaran, Esther Sathya Bama Benjamin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 4, 2019
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantationAswin Anand Pai, Anup J Devasia, John Carl Panetta, et al.
Pharmacogenomics and Personalized Medicine|October 11, 2021
<i>NUDT15</i> c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance TherapyAswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, et al.
Molecular Therapy. Nucleic Acids|May 31, 2024
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editorsKirti Prasad, Nivedhitha Devaraju, Anila George, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Plos One|October 26, 2023
Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantationBalaji Balakrishnan, Raveen Stephen Stallon Illangeswaran, Bharathi Murugan Rajamani, et al.
Stem Cell Research & Therapy|December 31, 2024
Enhanced fetal hemoglobin production via dual-beneficial mutation editing of the HBG promoter in hematopoietic stem and progenitor cells for β-hemoglobinopathiesPrathibha Babu Chandraprabha, Manoj Kumar K Azhagiri, Vigneshwaran Venkatesan, et al.
Transplantation and Cellular Therapy|May 13, 2022
Endothelial Activation and Stress Index-Measured Pretransplantation Predicts Transplantation-Related Mortality in Patients with Thalassemia Major Undergoing Transplantation with Thiotepa, Treosulfan, and Fludarabine ConditioningUday P Kulkarni, Aswin Anand Pai, M L Kavitha, et al.
Scientific Reports|August 18, 2022
Erythroid lineage-specific lentiviral RNAi vectors suitable for molecular functional studies and therapeutic applicationsAbhirup Bagchi, Nivedhitha Devaraju, Karthik Chambayil, et al.
Cells|April 3, 2021
Direct Generation of Immortalized Erythroid Progenitor Cell Lines from Peripheral Blood Mononuclear CellsAbhirup Bagchi, Aneesha Nath, Vasanth Thamodaran, et al.
Frontiers in Genome Editing|January 6, 2023
Efficient and error-free correction of sickle mutation in human erythroid cells using prime editor-2Anila George, Nithin Sam Ravi, Kirti Prasad, et al.
Frontiers in Pharmacology|June 16, 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib <i>in vitro</i> and reduces disease burden <i>in vivo</i>Bharathi M Rajamani, Raveen Stephen Stallon Illangeswaran, Esther Sathya Bama Benjamin, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 4, 2019
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell TransplantationAswin Anand Pai, Anup J Devasia, John Carl Panetta, et al.
Pharmacogenomics and Personalized Medicine|October 11, 2021
<i>NUDT15</i> c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance TherapyAswin Anand Pai, Ajith Mohan, Esther Sathya Bama Benjamin, et al.
Molecular Therapy. Nucleic Acids|May 31, 2024
Precise correction of a spectrum of β-thalassemia mutations in coding and non-coding regions by base editorsKirti Prasad, Nivedhitha Devaraju, Anila George, et al.
Pageof 4